Discontinuation report SEHCAT
| Report ID | 277848 |
| Drug Identification Number | 02329050 |
| Brand name | SEHCAT |
| Common or Proper name | Selenium (75Se) (tauroselcholic acid) |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TAUROSELCHOLIC ACID |
| Strength(s) | 370KBq |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 1 capsule |
| Anatomical Therapeutical Chemical (ATC) code | V09DX |
| Anatomical Therapeutical Chemical (ATC) description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-04-14 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-02-12 | French | Compare |
| v3 | 2026-02-12 | English | Compare |
| v2 | 2026-02-12 | English | Compare |
| v1 | 2026-02-12 | English | Compare |
Showing 1 to 4 of 4